Clinical Investigation on the Effects of a Vegetable Juice Treatment

NCT ID: NCT01161706

Last Updated: 2010-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE1

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2009-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the investigators study is to investigate the impact of a commercial vegetable juice on dietary vegetable intake and select cardiovascular risk factors in a generally healthy population. The study was a 12 week study with 3 groups who received 0, 8 or 16 fluid ounces daily of vegetable juice, along with education on the DASH (Dietary Approaches to Stop Hypertension) diet. All participants came in for 3 study visits at 0, 6 and 12 weeks into the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vegetables Cardiovascular Disease Blood Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

0 fluid ounces vegetable juice plus dietary education on the DASH (Dietary Approaches to Stop Hypertension) diet

Group Type NO_INTERVENTION

No interventions assigned to this group

8 fluid ounces vegetable juice

8 fluid ounces vegetable juice plus dietary education on the DASH (Dietary Approaches to Stop Hypertension) diet

Group Type EXPERIMENTAL

Vegetable Juice

Intervention Type OTHER

Participants consumed vegetable juice daily in the amount of 0, 8 or 16 fluid ounces.

16 fluid ounces vegetable juice

16 fluid ounces vegetable juice plus dietary education on the DASH (Dietary Approaches to Stop Hypertension) diet

Group Type EXPERIMENTAL

Vegetable Juice

Intervention Type OTHER

Participants consumed vegetable juice daily in the amount of 0, 8 or 16 fluid ounces.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vegetable Juice

Participants consumed vegetable juice daily in the amount of 0, 8 or 16 fluid ounces.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Commercial vegetable juice provided by Campbell Soup Company

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 40 to 65 yrs
* Subject's body mass index is between 18.5 - 34.9 kg/m2
* Subject is willing and able to comply with the study protocols
* Subject is willing to consume a vegetable-based beverage daily for three months

Exclusion Criteria

* Physical signs of health impairment
* Uncontrolled diabetes or hypertension
* Pregnant or lactating
* Active tuberculosis or lung disease (i.e. COPD)
* Renal or Liver disease
* Heart Disease, which includes Cardiovascular events and Stroke
* Cushing's syndrome
* Exercise trained individuals
* History of psychiatric disorders i.e. schizophrenia or bi-polar or depression treated with antidepressants within the last 1 year
* Anxiety medications
* Use of MAOI inhibitors within the last 1 year (e.g., phenelzine (Nardil), tranylcypromine (Parnate), etc.)
* Quality of life score of 21 or above
* Routine use of prescription drugs or over-the counter medications, which may potentially modulate the outcome of this study; including antibiotics, aspirin and aspirin-containing formulations, COX-2 inhibitors, antihistamines, corticosteroids, erectile dysfunction drugs
* Asthma (can be worsened by mild to moderate food allergies)
* Indications of substance or alcohol abuse within the last 3 years
* The volunteer is undergoing nicotine cessation therapy
* Laboratory values outside the reference range if determined to be clinically significant by Dr. M. Eric Gershwin
* Individuals with known salt-sensitive hypertension
* History of stage 1 high blood pressure defined as systolic \> 140 and diastolic \> 90, with or without use of HTN medications
* Multi-Vitamin use other than a One-A-Day essential
* Use of herbal or plant-based supplements; omega-3 fatty acids, and fish oils and unwilling to discontinue use while participating in the study
* Allergies to vegetables
Minimum Eligible Age

40 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Davis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of California, Davis

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carl L Keen, PhD

Role: PRINCIPAL_INVESTIGATOR

Professor of Nutrition

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ragle Human Nutrition Research Center (1283 Academic Surge)

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Shenoy SF, Kazaks AG, Holt RR, Chen HJ, Winters BL, Khoo CS, Poston WS, Haddock CK, Reeves RS, Foreyt JP, Gershwin ME, Keen CL. The use of a commercial vegetable juice as a practical means to increase vegetable intake: a randomized controlled trial. Nutr J. 2010 Sep 17;9:38. doi: 10.1186/1475-2891-9-38.

Reference Type DERIVED
PMID: 20849620 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

200614971

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Watermelon on Cardiometabolic Health
NCT07006636 NOT_YET_RECRUITING NA
The Purple Grape Juice Study
NCT00551746 COMPLETED NA